CHS Pharma, Inc.
Records under this name other than the patents CHS Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.
Showing 1 to 10 of 10 · Back to CHS Pharma, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,827,220 | Treatment for ischemic stroke Lapsed on the fee record Ended Nov 28, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 28, 2025 | From the USPTO record |
| US 9,050,305 | Treatment for ischemic stroke Lapsed on the fee record Ended Jun 9, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 9, 2023 | From the USPTO record |
| US 8,871,971 | Protection of normal cells Lapsed on the fee record Ended Oct 28, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 28, 2022 | From the USPTO record |
| US 8,765,808 | Treatment or prevention of cancer and precancerous disorders Formerly held Lapsed on the fee record Ended Jul 1, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 1, 2022 | From the USPTO record |
| US 8,603,985 | Treatment or prevention of cancer and precancerous disorders Formerly held Lapsed on the fee record Ended Dec 10, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2021 | From the USPTO record |
| US 8,258,181 | Treatment or prevention of cancer and precancerous disorders Formerly held Lapsed on the fee record Ended Sep 4, 2020 · From the USPTO record | Lapsed on the fee record | Ended Sep 4, 2020 | From the USPTO record |
| US 7,414,139 | Catalytic antioxidants and methods of use Formerly held Lapsed on the fee record Ended Aug 19, 2020 · From the USPTO record | Lapsed on the fee record | Ended Aug 19, 2020 | From the USPTO record |
| US 8,487,128 | Protection of normal cells Formerly held Lapsed on the fee record Ended Jul 16, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jul 16, 2017 | From the USPTO record |
| US 8,357,720 | Treatment or prevention of cancer and precancerous disorders Formerly held Lapsed on the fee record Ended Jan 22, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2017 | From the USPTO record |
| US 7,129,374 | Catalytic antioxidants and methods of use Formerly held Lapsed on the fee record Ended Oct 31, 2014 · From the USPTO record | Lapsed on the fee record | Ended Oct 31, 2014 | From the USPTO record |